摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-氯-3,5-二溴吡啶 | 40360-47-2

中文名称
2-氯-3,5-二溴吡啶
中文别名
3,5-二溴-2-氯吡啶;2-氯-3,5-二溴嘧啶
英文名称
2-chloro-3,5-dibromopyridine
英文别名
3,5-dibromo-2-chloropyridine;3,5-dibromo-2-chloro-pyridine;3,5-Dibrom-2-chlor-pyridin;2-Chlor-3,5-dibrom-pyridin
2-氯-3,5-二溴吡啶化学式
CAS
40360-47-2
化学式
C5H2Br2ClN
mdl
——
分子量
271.339
InChiKey
PYSICVOJSJMFKP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    42-44°C
  • 沸点:
    257.1±35.0 °C(Predicted)
  • 密度:
    2.136±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    9
  • 可旋转键数:
    0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    12.9
  • 氢给体数:
    0
  • 氢受体数:
    1

安全信息

  • 危险等级:
    IRRITANT
  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39,S37,S37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2933399090
  • 危险性防范说明:
    P261,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H335
  • 储存条件:
    存储条件:室温,密封保存。

SDS

SDS:5c7e4eab328a00281c3200e456b5bbdf
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 3,5-Dibromo-2-chloropyridine
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
Avoid breathing dust/fume/gas/mist/vapours/spray
P261:
P280: Wear protective gloves/protective clothing/eye protection/face protection
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing
P304+P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing
P405: Store locked up

Section 3. Composition/information on ingredients.
Ingredient name: 3,5-Dibromo-2-chloropyridine
CAS number: 40360-47-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C5H2Br2ClN
Molecular weight: 271.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    2-氯-3,5-二溴吡啶lithium diisopropyl amide 作用下, 以 四氢呋喃 为溶剂, 反应 1.5h, 以72%的产率得到3,3',5,5'-tetrabromo-2,2'-dichloro-4,4'-bipyridine
    参考文献:
    名称:
    手性六氢杂合的4,4'-联吡啶
    摘要:
    描述了通过两种互补方法制备手性六卤代-4,4'-联吡啶的27种异构体。第一种是收敛的,基于LDA诱导的三卤代吡啶的4,4'-二聚,而第二种方法是分歧的,是通过4,4'-联吡啶-2,2'-二酮的区域选择性卤化反应实现的。通过对2,2′-二溴衍生物进行的铜催化的Finkelstein反应(Buchwald方法)引入4,4′-联吡啶的2,2′-位处的碘。通过手性固定相上的高效液相色谱对映这种新的对映异构体4,4'-联吡啶家族的选定化合物,对映体分离,并使用X射线衍射分析确定分离的对映体的绝对构型。
    DOI:
    10.1021/acs.joc.6b00413
  • 作为产物:
    描述:
    2-甲氧基-3,5-二溴吡啶三氯氧磷 作用下, 以 N,N-二甲基甲酰胺 为溶剂, 反应 16.0h, 以62%的产率得到2-氯-3,5-二溴吡啶
    参考文献:
    名称:
    Shiao, Min-Jen; Shyu, Li-Ming; Tarng, Kai-Yih, Synthetic Communications, 1990, vol. 20, # 19, p. 2971 - 2977
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • 芳氧基苯胺基丙酸酯类化合物及其作为除草剂的应用
    申请人:长江大学
    公开号:CN105439945A
    公开(公告)日:2016-03-30
    芳氧基苯胺基丙酸酯类化合物,包括如下通式(I)表示的结构:其中,Ar为杂芳环或者稠杂环;杂芳环为稠杂环为R1、R2、R3、R4为H、卤素、硝基、甲氧基、甲基、甲酸甲酯基、基或三卤甲基中的一种或者几种;R5为H、C1~C4的直链或者支链的烷基,烷基上的氢被羟基、羧基、巯基、基、基、苯基取代;R6为甲基、乙基、丁基、中的一种;其优点是:此结构化合物,能保持芳氧苯氧丙酸酯类除草剂高效、速效、不易产生抗性等优点;同时可设计分子中的氨基酸官能团作为掺假氨基酸,抑制植物本身蛋白质的生物合成,对所有杂草具有防除作用。
  • Large-Scale Solvent-Free Chlorination of Hydroxy-Pyrimidines, -Pyridines, -Pyrazines and -Amides Using Equimolar POCl3
    作者:Han Wang、Kun Wen、Le Wang、Ye Xiang、Xiaocheng Xu、Yongjia Shen、Zhihua Sun
    DOI:10.3390/molecules17044533
    日期:——
    Chlorination with equimolar POCl3 can be efficiently achieved not only for hydroxypyrimidines, but also for many other substrates such as 2-hydroxy-pyridines, -quinoxalines, or even -amides. The procedure is solvent-free and involves heating in a sealed reactor at high temperatures using one equivalent of pyridine as base. It is suitable for large scale (multigram) batch preparations.
    使用等摩尔量的POCl3对羟基嘧啶进行化不仅是有效的,而且对许多其他底物,如2-羟基吡啶喹唑啉或甚至酰胺也是如此。该过程是无溶剂的,涉及在密封反应器中高温加热,使用一当量的吡啶作为碱。它适用于大规模(多克级)批次制备。
  • Efficient Phosphorus-Free Chlorination of Hydroxy Aza-Arenes and Their Application in One-Pot Pharmaceutical Synthesis
    作者:Jian Wang、Yan-Hui Li、Song-Cheng Pan、Ming-Fang Li、Wenting Du、Hong Yin、Jing-Hua Li
    DOI:10.1021/acs.oprd.9b00407
    日期:2020.2.21
    The chlorination of hydroxy aza-arenes with bis(trichloromethyl) carbonate (BTC) and SOCl2 has been effectively performed by refluxing with 5 wt % 4-dimethylaminopyridine (DMAP) as a catalyst. Various substrates are chlorinated with high yields. The obtained chlorinated aza-arenes can be used directly with simple workup for succedent one-pot synthesis on a large scale.
    碳酸二(三甲基)酯(BTC)和SOCl 2化羟基氮杂芳烃已经通过与5重量%的4-二甲基氨基吡啶DMAP)作为催化剂回流而有效地进行。各种底物都可以高产率化。所获得的氯化氮芳烃可通过简单的后处理直接直接用于大规模的一锅合成。
  • STRAIGHTFORWARD ENTRY TO 7-AZABICYCLO[2.2.1]HEPTANE-1-CARBONITRILES AND SUBSEQUENT SYNTHESIS OF EPIBATIDINE ANALOGUES
    申请人:STEVENS Christian
    公开号:US20090275616A1
    公开(公告)日:2009-11-05
    The present invention relates to a group of substituted-7-azabicyclo-[2.2.1]heptyl derivatives with biological activity. The present invention also relates to synthetic methods for producing said substituted-7-azabicyclo-[2.2.1]heptyl derivatives. The present invention also relates to certain intermediates for producing such substituted-7-azabicyclo-[2.2.1]heptyl derivatives, as well as a synthetic method for producing such intermediates. The present invention also relates to pharmaceutical compositions comprising such substituted-7-azabicyclo-[2.2.1]heptyl derivatives, as well as their use as medicaments for the treatment of diseases mediated by a Nicotinic Acetylcholine Receptor or a receptor being a member of the Neurotransmitter-gated Ion Channel Superfamily, such as pain, Alzheimer's disease, Parkinson's disease, schizophrenia, epilepsy and nicotine addiction.
    本发明涉及一组具有生物活性的取代-7-氮杂双环[2.2.1]庚基衍生物。本发明还涉及用于制备所述取代-7-氮杂双环[2.2.1]庚基衍生物的合成方法。本发明还涉及用于制备此类取代-7-氮杂双环[2.2.1]庚基衍生物的某些中间体,以及用于制备此类中间体的合成方法。本发明还涉及包含此类取代-7-氮杂双环[2.2.1]庚基衍生物的药物组合物,以及它们作为治疗由尼古丁乙酰胆碱受体或神经递质门控离子通道超家族成员介导的疾病的药物的用途,如疼痛、阿尔茨海默病、帕森病、精神分裂症、癫痫和尼古丁成瘾。
  • Efficient Use of 1,2-Dihaloazine Synthons in Transition-Metal-Free Preparation of Diverse Heterocycle-Fused 1,4-Oxazepines
    作者:Alexander V. Sapegin、Stanislav A. Kalinin、Alexey V. Smirnov、Mikhail V. Dorogov、Mikhail Krasavin
    DOI:10.1002/ejoc.201403397
    日期:2015.2
    A previously reported condensation reaction of ambiphilic 2-(1H-pyrazol-5-yl)phenols with various o-chloro-substituted nitroaromatic synthons to provide medicinally important tetracyclic pyrazolo[1,5-d][1,4]oxazepines was extended to more readily available and convenient-to-use 1,2-dihaloazines. Although 4,5-dichloropyridazin-3(2H)-ones and 2,3-dichloropyrazine are popular bis(electrophilic) partners
    先前报道的两亲性 2-(1H-pyrazol-5-yl) 苯酚与各种邻取代的硝基芳族合成子的缩合反应可提供具有药用价值的四环吡唑并 [1,5-d][1,4] 氧氮杂更容易获得和使用方便的 1,2-二卤嗪。尽管 4,5-二哒嗪-3(2H)-酮和 2,3-二氯吡嗪是各种 SNAr 型缩合中常用的双(亲电)伙伴,并且也有效地用于本文报道的反应,各种 3-溴-2-氯吡啶经历相同的环化是出乎意料的。
查看更多

同类化合物

(S)-氨氯地平-d4 (R,S)-可替宁N-氧化物-甲基-d3 (R)-(+)-2,2'',6,6''-四甲氧基-4,4''-双(二苯基膦基)-3,3''-联吡啶(1,5-环辛二烯)铑(I)四氟硼酸盐 (R)-N'-亚硝基尼古丁 (R)-DRF053二盐酸盐 (5E)-5-[(2,5-二甲基-1-吡啶-3-基-吡咯-3-基)亚甲基]-2-亚磺酰基-1,3-噻唑烷-4-酮 (5-溴-3-吡啶基)[4-(1-吡咯烷基)-1-哌啶基]甲酮 (5-氨基-6-氰基-7-甲基[1,2]噻唑并[4,5-b]吡啶-3-甲酰胺) (2S,2'S)-(-)-[N,N'-双(2-吡啶基甲基]-2,2'-联吡咯烷双(乙腈)铁(II)六氟锑酸盐 (2S)-2-[[[9-丙-2-基-6-[(4-吡啶-2-基苯基)甲基氨基]嘌呤-2-基]氨基]丁-1-醇 (2R,2''R)-(+)-[N,N''-双(2-吡啶基甲基)]-2,2''-联吡咯烷四盐酸盐 (1'R,2'S)-尼古丁1,1'-Di-N-氧化物 黄色素-37 麦斯明-D4 麦司明 麝香吡啶 鲁非罗尼 鲁卡他胺 高氯酸N-甲基甲基吡啶正离子 高氯酸,吡啶 高奎宁酸 马来酸溴苯那敏 马来酸氯苯那敏-D6 马来酸左氨氯地平 顺式-双(异硫氰基)(2,2'-联吡啶基-4,4'-二羧基)(4,4'-二-壬基-2'-联吡啶基)钌(II) 顺式-二氯二(4-氯吡啶)铂 顺式-二(2,2'-联吡啶)二氯铬氯化物 顺式-1-(4-甲氧基苄基)-3-羟基-5-(3-吡啶)-2-吡咯烷酮 顺-双(2,2-二吡啶)二氯化钌(II) 水合物 顺-双(2,2'-二吡啶基)二氯化钌(II)二水合物 顺-二氯二(吡啶)铂(II) 顺-二(2,2'-联吡啶)二氯化钌(II)二水合物 韦德伊斯试剂 非那吡啶 非洛地平杂质C 非洛地平 非戈替尼 非布索坦杂质66 非尼拉朵 非尼拉敏 雷索替丁 阿雷地平 阿瑞洛莫 阿扎那韦中间体 阿培利司N-6 阿伐曲波帕杂质40 间硝苯地平 间-硝苯地平 镉,二碘四(4-甲基吡啶)- 锌,二溴二[4-吡啶羧硫代酸(2-吡啶基亚甲基)酰肼]-